CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


Biogen Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



BIIB EBITDA Margin (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Revenue Change -23.78 % -22.3 % -6.22 % 1.79 % 1.28 %
Y / Y EBITDA Change -66.26 % -75.93 % -48.22 % 22.29 % -8.17 %
EBITDA Margin 22.79 % 15.54 % 32.34 % 58.41 % 51.48 %
EBITDA Margin Total Ranking # 1049 # 1855 # 1088 # 412 # 486
Seq. Revenue Change -5.56 % -15.51 % -8.3 % 4.17 % -3.73 %
Seq. EBITDA Change 38.52 % -59.41 % -49.23 % 18.2 % -1.2 %


Commenting First Quarter 2021 EBITDA Margin
Despite sequential Revenue deterioration in I. Quarter of -5.56 % Biogen Inc managed to reduce Operating Costs and increase EBITDA by 38.52 % to $614 millions. EBITDA Margin grew to 22.79 %, below company average EBITDA Margin.

Observing first quarter 2021 results within Biotechnology & Drugs industry 14 other companies have achieved higher EBITDA Margin. While EBITDA Margin total ranking has impoved so far to 1049, from total ranking in previous quarter at 1855.
Learn about Operating Margin
BIIB's EBITDA Margin first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 15
Healthcare Sector # 73
Overall # 1049

EBITDA Margin Statistics
High Average Low
75.83 % 43.28 % 15.54 %
(Dec. 31, 2007)   (Dec 31 2020)



Financial Statements
Biogen Inc 's (Mar 31 2021) EBITDA $ 614 BIIB's Income Statement
Biogen Inc 's (Mar 31 2020) EBITDA $ 1,819 Quarterly BIIB's Growth
BIIB's Profits by Division See BIIB's Profits by Segment

Other EBITDA Margin Profitability Ratios
BIIB's Cumulative EBITDA Margin
Biotechnology & Drugs Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
BIIB's EBITDA Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for BIIB's Competitors
EBITDA Margin Profit Margin for Biogen Inc 's Suppliers
EBITDA Margin Profit Margin for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's EBITDA Growth
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Mar 31 2021, within Biotechnology & Drugs Industry EBITDA MarginMar 31 2021 MRQ EBITDAMar 31 2021 MRQ Revenue
La Jolla Pharmaceutical Company  52.47 %$ 17.910 $ 34.137 
Abbvie Inc   51.53 %$ 6,704.000 $ 13,010.000 
Jounce Therapeutics inc   51.01 %$ 0.785 $ 1.539 
Gilead Sciences Inc   46.61 %$ 2,994.000 $ 6,423.000 
Meridian Bioscience Inc   43.66 %$ 37.230 $ 85.264 
Emergent Biosolutions Inc   35.98 %$ 123.400 $ 343.000 
Royalty Pharma Plc  34.27 %$ 196.394 $ 573.027 
Repligen Corp  33.24 %$ 47.483 $ 142.837 
Tarsus Pharmaceuticals Inc   30.32 %$ 10.136 $ 33.432 
Bio techne Corp  27.29 %$ 66.457 $ 243.552 
Gritstone Bio Inc   24.05 %$ 9.545 $ 39.693 
Biogen Inc   22.79 %$ 613.900 $ 2,694.000 
Avantor Inc   19.93 %$ 355.800 $ 1,785.600 
Sangui Biotech International Inc  19.11 %$ 0.004 $ 0.021 
Neogen Corp  18.73 %$ 21.855 $ 116.709 
Reynolds Consumer Products Inc   18.10 %$ 137.000 $ 757.000 
Neurocrine Biosciences Inc   17.03 %$ 40.300 $ 236.600 
Heska Corporation  6.75 %$ 4.085 $ 60.503 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NMRK's Profile

Stock Price

NMRK's Financials

Business Description

Fundamentals

Charts & Quotes

NMRK's News

Suppliers

NMRK's Competitors

Customers & Markets

Economic Indicators

NMRK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071